ChronLAW.com News for attorneys, lawyers, and insurance, banking, credit, finance, government, education and law related professionals, covering politics, business, medicine, crime, law enforcement and other legal topics.
Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update – StreetInsider.com
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 millionClinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02Cash reserves of $5.8 million at December 31, 2020 plus funds from IPO provide funding for at least 12 months from the date of completion of …
